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A B S T R A C T   
Cell-assembled extracellular matrix (CAM) has been used to produce vascular grafts. While these completely 
biological vascular grafts performed well in clinical trials, the in vivo remodeling and inflammatory response of 
this truly “bio” material has not yet been investigated. In this study, human CAM yarns were implanted sub-
cutaneously in nude rats to investigate the innate immune response to this matrix. The impact of processing steps 
relevant to yarn manufacturing was evaluated (devitalization, decellularization, gamma sterilization, and 
twisting). We observed that yarns were still present after six months, and were integrated into a non-inflamed 
loose connective tissue. The CAM was repopulated by fibroblastic cells and blood vessels. While other yarns 
caused minor peripheral inflammation at an early stage (two weeks of implantation), gamma sterilization trig-
gered a more intense host response dominated by the presence of M1 macrophages. The inflammatory response 
was resolved at six months. Yarn mechanical strength was decreased two weeks after implantation except for the 
more compact “twisted” yarn. While the strength of other yarns was stable after initial remodeling, the gamma- 
sterilized yarn continued to lose mechanical strength over time and was weaker than devitalized (control) yarns 
at six months. This is the first study to formally demonstrate that devitalized human CAM is very long-lived in 
vivo and does not trigger a degradative response, but rather is very slowly remodeled. This data supports a 
strategy to produce human textiles from CAM yarn for regenerative medicine applications where a scaffold with 
low inflammation and long-term mechanical properties are critical.   
1. Introduction 
Over the past ten years, vascular tissue engineering has flourished 
with two approaches to produce arterial bypass grafts reaching clinical 
trials [1,2]. We pioneered the use of cell-assembled extracellular matrix 
(CAM) synthesized in vitro by human skin fibroblasts as a robust bio-
logical scaffold to produce vascular grafts without exogenous materials 
[3,4]. Living and autologous blood vessels constructed by rolling sheets 
of CAM were the first tissue-engineered vascular grafts (TEVGs) to be 
implanted in the human arterial circulation [1,5]. Moreover, allogeneic 
TEVGs, that were devitalized by a simple dehydration process, have 
been implanted in patients without signs of rejection, which opened the 
door to an “off-the-shelf” approach for vascular tissue engineering [6]. 
While CAM-based vascular grafts rapidly reached the clinic with suc-
cessful outcomes, the in vivo remodeling of this “bio” material has not 
been carefully studied. Indeed, the grafts were rarely retrieved during 
the clinical trial because TEVGs were implanted as arteriovenous shunts 
in complex patients with multiple comorbidities. Furthermore, the 
intense inflammatory environment of a failed arteriovenous shunt, 
which was punctured three times per week with two large-bore needles, 
likely masked the body’s normal remodeling response to the CAM tissue. 
The production of TEVGs by rolling sheets of CAM requires a first 
step of culture within sterile flasks (approximately ten weeks) followed 
by a period of maturation (approximately ten additional weeks) using a 
bioreactor to fuse the various layers of the blood vessel [1,3–7]. In order 
to provide a much faster and economical production strategy, we 
recently developed TEVGs using a textile approach [8]. Biological yarns 
were produced by cutting strips of CAM to obtain “ribbons”, which could 
be further processed into “threads” by twisting them. These yarns (rib-
bons or threads) can be devitalized by a simple dehydration process and 
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stored dry until needed. By weaving this human yarn, devitalized TEVGs 
with impressive mechanical strength can be produced in a few days. This 
approach could be readily automated, which would further significantly 
reduce production time (cost) and improve the quality and the repro-
ducibility of the textile. 
In this study, we analyzed the in vivo remodeling of the devitalized 
CAM in a controlled environment using a simple implant (a yarn), which 
allowed for both straightforward histological and mechanical evalua-
tions. In addition, we examined whether different processing steps that 
are relevant to the manufacturing of an implantable textile, such as 
decellularization, gamma sterilization, or twisting, would adversely 
affect yarn integrity or its in vivo remodeling. Therefore, processed 
human yarns were subcutaneously implanted in athymic nude rats for 
up to six months. This well-established animal model allowed the 
evaluation of the innate immune response without interference from the 
adaptive immune system that would reject the human tissue [9]. Eval-
uating the responses to these yarns will indicate which processing ap-
proaches are acceptable for the manufacturing of a woven TEVG or other 
human textiles. 
2. Materials and methods 
2.1. Human skin fibroblast culture and CAM production 
Human skin fibroblast cells (HSFs) were isolated from healthy adult 
patients according to our previously described protocol [4]. The HSFs 
were grown in Dulbecco’s modified Eagle medium containing F-12 
nutrient mixture (DMEM/F-12; 31331-028; Gibco®, ThermoFisher Sci-
entific, Bordeaux, France) supplemented with 20% fetal bovine serum 
(FBS) (Hyclone SH30109.03, GE Healthcare Life Science, Washington, 
WA, USA) in humidified 37 ◦C incubators with 5% CO2 and frozen at the 
end of the 3rd passage. For the production of the CAM, frozen cells were 
thawed in passage 4 (P4) and cultured for one week. HSFs were seeded 
at a density of 1 × 104 cell/cm2 (P5) in 225 cm2 flasks and cultured for 
approximately eight weeks in medium supplemented with 500 μM of 
sodium L-ascorbate (A4034-500G; Sigma-Aldrich, Saint-Quentin-Fal-
lavier, France). The media was changed three times per week. 
2.2. CAM devitalization 
CAM sheets were quickly rinsed in sterile distilled water and frozen 
at − 80 ◦C. Sheets were then thawed, quickly rinsed in sterile distilled 
water, air-dried under the sterile flow of a biosafety cabinet at room 
temperature for at least 2 h, and stored at − 80 ◦C until needed. For yarn 
production, sheets were rehydrated in water, cut to desired dimensions, 
and air-dried under the sterile flow of a biosafety cabinet at room 
temperature for at least 2 h. Dry CAM yarns were spooled and stored at 
− 80 ◦C. 
2.3. CAM decellularization 
The decellularization process was realized on devitalized CAM 
sheets. CAM sheets, devitalized as described in section 2.2, were rehy-
drated using sterile distilled water for at least 1 h. The water was then 
replaced with 150 mL of a decellularization solution composed of 8 mM 
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS; Sigma-Aldrich, Saint-Quentin-Fallavier, France), 1000 mM 
sodium chloride (NaCl; S9888-1 KG; Sigma-Aldrich, Saint-Quentin-Fal-
lavier, France), 25 mM ethylenediaminetetraacetic acid (EDTA; EDS- 
1KG; Sigma-Aldrich, Saint-Quentin-Fallavier, France), and 120 mM so-
dium hydroxide (NaOH; 30620-1 KG; Sigma-Aldrich, Saint-Quentin- 
Fallavier, France) diluted in 1X phosphate buffer saline (1X PBS; 
10010023; Gibco®, ThermoFisher Scientific, Bordeaux, France). The 
CAMs were treated for 6 h under intense rocking agitation. Then, the 
CAM sheets were rinsed three times in 1X PBS for 30 min and once in 
sterile distilled water overnight under agitation. Finally, the 
decellularized CAM tissues were stored in sterile distilled water at 4 ◦C 
for 24 h before being processed for nucleus imaging, histology, or pro-
duction of decellularized yarns. 
2.4. Production of devitalized, decellularized, and twisted yarns 
Yarns were produced as previously described [8]. CAM sheets were 
placed on a sterilized custom cutting device. A series of circular blades, 
separated by 5-mm spacers, was pressed and rolled on the sheet to 
produce ribbons (16- to 18-cm long). Ribbon yarns were subsequently 
dried under sterile condition, individually spooled around sterile sup-
ports, placed in sterile tubes, and stored at − 80 ◦C. To produce twisted 
yarn (threads), one extremity of the rehydrated ribbon was attached to 
the rotating rod of a custom twisting device, while a manipulator 
pinched the other extremity. The calibrated motor was turned on for a 
calculated duration to twist the ribbons at 7.5 revolutions per cm of 
length, while the manipulator manually massaged the yarn. 
2.5. Gamma sterilization of the devitalized yarns 
Gamma sterilization was performed on spooled devitalized yarns 
that were previously dried. They were taken out of the − 80 ◦C freezer 
and shipped in tubes, at ambient temperature, to the company Steris 
(Marcoule, France). They were exposed for 3 h and received a 25 kGy 
irradiation dose generated by a source of 60Cobalt. 
2.6. Subcutaneous implantation of the yarns in nude rats 
Nude rats were anesthetized using isoflurane gas, and incision sites 
were disinfected with ethanol. Small punctures were made in the skin, at 
shoulder level and on the lower back, with a 18G needle. Devitalized, 
decellularized, gamma sterilized, and twisted yarns (rehydrated with 
sterile 1X PBS) were inserted in the eye of a sterile 17-cm long needle. 
Four yarns were implanted per rat. Three-mm wide ribbons of a clini-
cally used membrane of processed bovine collagen (BioMend®; 0107; 
Zimmer Biomet Dental, Rungis, France) were used as a positive control 
to prove that the innate immune system of the nude rats was functional. 
After implantation, antibiotics were sprayed at the incisions sites. 
Samples were explanted at two weeks, as well as one, three, and six 
months after implantation. Eight samples per condition per time point 
were implanted into two animals (n = 8 grafts/condition/time point). 
All procedures and animal treatments complied with the principles of 
laboratory animal care formulated by the national society for medical 
research. This study was carried out in an accredited animal facility and 
was approved by the animal ethics committee of the University of 
Bordeaux. 
2.7. Histological analyses 
Samples were fixed overnight in 4% paraformaldehyde (PFA), 
rinsed, dehydrated, and paraffin-embedded. Seven-μm-thick paraffin- 
embedded sample sections were colored with Hematoxylin-Eosin 
staining (H&E). Images were captured using a NanoZoomer S60 digi-
tal slide scanner (C13210-01; Hamamatsu; Massy, France). 
2.8. Indirect immunofluorescent staining against matrix proteins 
Samples were fixed in 4% PFA overnight. After two rinses in 1X PBS, 
samples were dehydrated and embedded in paraffin. Paraffin sections (7 
μm) were deparaffinized in toluene, followed by a descending series of 
ethanol, and those were processed for immunofluorescent staining. 
Deparaffinized sections were pretreated with citrate (pH 6.0) for 20 min 
at 95 ◦C and then washed with 1X PBS. Samples were immersed in 
blocking solution (3% goat normal serum diluted in 1X PBS) for 30 min 
at room temperature. Then, samples were incubated overnight at 4 ◦C 
with rabbit polyclonal primary antibodies against either collagen-I 
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(ab34710; Abcam, Cambridge, UK), fibronectin (ab23750; Abcam), or 
thrombospondin (ab85762; Abcam) diluted in blocking solution 
(1:200). Negative controls received blocking solution only. Following a 
washing step, the secondary antibodies Alexa Fluor 568-conjugated goat 
anti-rabbit (1:300; A-11036; Invitrogen, Barcelona, Spain) and 4′,6- 
diamidino-2-phenylindole (DAPI; 1:1000; D1306; Invitrogen) were 
applied for 2 h at room temperature. Images were acquired using a 
confocal microscope (TCS SPE, Leica microsystems, Wetzlar, Germany). 
2.9. M1/M2 macrophages imaging and quantification 
Inflammation generated by the presence of the yarns was quantified 
at two weeks, as well as one, three, and six months after implantation. 
Explanted samples of the yarns were processed as described in section 
2.8 for M1/M2 immunostaining. M1 cells were double-stained with 
rabbit polyclonal antibodies against CCR7 (1:100; ab32527; Abcam) and 
mouse polyclonal antibodies against CD68 (1:100; ab31630; Abcam). 
M2 cells were double-stained with rabbit polyclonal antibodies against 
CD206 (1:100; ab64693; Abcam) and mouse polyclonal antibodies 
against CD68 (1:100; ab31630; Abcam). Secondary antibodies Alexa 
Fluor 568-conjugated goat anti-rabbit (A-11036; Invitrogen) and Alexa 
Fluor 488-conjugated goat anti-mouse (A-11001; Invitrogen) were 
diluted (1:300) in the presence of DAPI (1:1000) and applied for 2 h at 
room temperature. Images were acquired using a confocal microscope 
(TCS SPE, Leica microsystems). Quantification of M1 cells (CD68 and 
CCR7 positive cells) and M2 cells (CD68 and CD206 positive cells) was 
performed using a macro in ImageJ® software (NIH, Bethesda, MD, 
USA). Briefly, the yellow signal (double staining green and red) was 
isolated (threshold) and particles of the approximate size of a macro-
phage (five pixels and beyond) were counted in a 100-μm wide band 
surrounding the yarn. (n = 2–3 representative yarns/condition/time 
point). 
2.10. Mechanical characterization of the yarns 
Yarn diameters were measured using a biaxial laser micrometer 
(XLS13XY; Xactum; AEROEL; Pradamano, Italy). Then, yarns were 
clamped in the jaws of a tensile testing machine (Criterion® 43; MTS; 
Berlin, Germany) equipped with a 250 N force sensor, pre-stretched at 
20 mm/min until reaching 0.1 N and pulled until rupture. The ultimate 
tensile stress (UTS) was calculated from the maximum force recorded 
during the test divided by the cross sectional area. (n = 4–15 yarns/ 
condition/time point). 
Fig. 1. Sterile yarn manufacturing. (A) Human skin fibroblasts were used to produce 10 × 18 cm2 sheets of CAM. Sheets were devitalized by dehydration and stored 
at − 80 ◦C to be available “off-the-shelf”. (B–C) To produce ribbons, rehydrated sheets were positioned on the bed of a custom cutting device, and circular blades were 
used to cut 5-mm wide CAM ribbons. (D) Ribbons were dried under tension in a biosafety cabinet. (E) Twisted yarn (thread) was produced using a custom twisting 
device where one extremity of the ribbon was attached to the rotation grip of the device, while the other extremity was held by a manipulator. Here, the twisting level 
was 7.5 revolutions per cm of length. 
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2.11. Statistical analyses 
All statistical analyses were performed with GraphPad Prism, 
Version 8 (GraphPad Software Inc. USA). Data are presented as mean ±
standard deviation (SD). Differences between the groups were deter-
mined using two-ways analysis of variance (ANOVA) with Tukey’s 
multiple comparison tests. Differences were considered significant at P 
< 0.05. 
3. Results 
3.1. Manufacturing of human biological yarns 
We have previously taken advantage of the ability of mesenchymal 
cells to assemble a dense endogenous extracellular matrix (ECM), we 
call Cell-Assembled Matrix (CAM), when cultured with ascorbate 
[10–12]. Here, robust sheets of CAM were produced using human skin 
fibroblasts in 225-cm2 flasks (Fig. 1A) that can then be cut into ribbons 
of various width using a multi-blade cutting device (Fig. 1B and C). 
Ribbons were air-dried under slight tension in a biosafety cabinet to 
generate a sterile yarn that was spooled and stored at − 80 ◦C (Fig. 1D). 
Alternatively, ribbons can be twisted to form “threads”, which are more 
compact and have different mechanical properties (Fig. 1E). 
3.2. Histological analyses of the yarns after processing 
While fresh CAM, containing living cells, can be processed into yarn 
(Fig. S1), our overall strategy is to produce “off-the-shelf”, fully bio-
logical, human textiles for regenerative medicine applications. 
Therefore, we have focused on the use of devitalized CAM (frozen/ 
thawed/dried) that can be stored at − 80 ◦C to maximize manufacturing 
flexibility. We also studied other processing steps, such as decellulari-
zation, gamma sterilization, and twisting, which may be relevant in the 
manufacturing of textile products. To observe structural changes in 
processed yarns, we performed histological analyses of cross-sections 
before implantation (Fig. 2). Devitalized yarns contained cell rem-
nants (dark purple) that could still be clearly identified in the dense 
collagenous matrix (pink) (Fig. 2A and B). The decellularization process 
removed all traces of nuclear material and did not affect the staining of 
the CAM (Fig. 2C and D). Confocal observations coupled with second 
harmonic generation (SHG) validated the efficacy of the decellulariza-
tion without affecting the collagenous network (Fig. S2). Conversely, 
gamma sterilization had a denaturing effect on the CAM (Fig. 2E and F). 
The dye had a decreased affinity for the collagenous matrix. Moreover, 
this treatment increased the delamination of the matrix. The twisting 
process compacted the devitalized CAM and gave a puckered appear-
ance to the CAM (Fig. 2G and H). These data suggest that the devitali-
zation process is a gentle treatment that did not affect the structural 
integrity of the CAM. 
3.3. Subcutaneous implantation of the yarns in a nude rat model 
In order to assess both histological and mechanical changes due to in 
vivo remodeling, we subcutaneously implanted long segments of CAM 
yarns (Fig. 3). The yarns were positioned from the lower back to the 
upper shoulders of nude rats using a 17 cm-long needle (Fig. 3A and B). 
The insertion of the needle created a subcutaneous tunnel where the 
yarn was implanted for two weeks, as well as one, three, and six months. 
Fig. 2. Histology of biological yarns. (A–H) H&E 
stained yarn cross-sections before implantation. (A 
and B) Devitalized yarn (Devit) displayed pycnotic 
and hyperchromatic nuclei (dark purple), indicative 
of cell death, embedded in a dense stratified ECM 
(pink). (C and D) Decellularized yarn (Decell) did not 
stain for nuclear material, confirming the efficiency of 
the decellularization process. (E and F) Both matrix 
and nuclei colorations of the gamma sterilized yarn 
(Gamma Ster) were reduced compared to their 
counterparts. (G and H) The twisting process led to 
the compaction of the tissue and the matrix. Scale 
bars; 250 μm (left panels) and 50 μm (right panels). 
(For interpretation of the references to color in this 
figure legend, the reader is referred to the Web 
version of this article.)   
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This simple implantation process illustrates how this material can be 
used just like a suture material [8]. Even six months after implantation, 
the yarns were easily visible and displayed no macroscopic signs of 
degradation, inflammation, scarring, or calcification (Fig. 3C). Yarn 
retrieval was somewhat challenging at longer implantation times 
because the material was well integrated into the surrounding tissue 
(Fig. 3D). Great care was taken to only explant the yarn and remove all 
surrounding tissues. We implanted strips of a commercially available 
membrane made from purified bovine collagen as a positive control for 
innate immune reaction (Fig. 3E). After one month of implantation, the 
membrane was so significantly degraded that it could not be retrieved 
for mechanical testing. Clearly, it had triggered a strong inflammatory 
response, as seen by the brown color of the remaining parts of the sample 
(Fig. 3F; black arrows). This confirmed that nude rats have a functional 
innate immune system capable of rapidly degrading denatured ECM. 
3.4. Histology of devitalized yarn after in vivo remodeling 
We then looked at the histology of implanted yarns to evaluate the 
inflammatory response and in vivo remodeling process. At two weeks, 
devitalized yarns were already well integrated with the surrounding 
tissue as judged by the close apposition to the native tissue (despite the 
histological processing), and the presence of migrating fibroblastic cells 
between and within the CAM layers (Fig. 4A). The fibroblastic nature of 
these cells was confirmed by immunostaining for type I procollagen 
(Fig. S3) [13,14]. Fibroblast remnants appeared as dark rounded 
structures in the CAM. Only mild inflammation was seen at the pe-
riphery of the implant, with no inflammatory foci, no giant cells, and no 
phagocytizing macrophages. Even at this early time point (two weeks), 
new blood vessels were already observed within the CAM layer 
(Fig. 4A). By one month, the yarn was tightly connected to the sur-
rounding tissue, colonizing fibroblastic host cells were seen deeper in 
the implant, blood vessels were seen within the yarn, and some rare 
immune cells (i.e., rounder cells with a non-fibroblastic phenotype) 
could still be identified around the tissue (Fig. 4B). No signs of degra-
dation were visible. After three and six months, cell density within the 
yarn decreased but fibroblastic cells were still present throughout the 
yarn (Fig. 4C, D and Fig. S4A). The tissue around the yarn appeared as 
normal loose connective tissue and not a fibrous encapsulation. Vascu-
larization and CAM layer thickness appeared to decrease with time but 
histological quantification did not show significant differences (Fig. S4B, 
C). Fresh CAM yarns containing living cells underwent a similar in vivo 
remodeling process (Fig. S1A-D). Survival of the human fibroblasts was 
confirmed by immunostaining for type I procollagen and human-specific 
nucleoli antigen expression (Fig. S1E,F). In contrast, the purified bovine 
collagen membrane was completely infiltrated by immune cells after 
two weeks, and actively phagocytizing macrophages were easily iden-
tified throughout the implant site (Fig. 4E). This data indicates that 
devitalized yarn rapidly integrates in the surrounding tissues with little 
signs of inflammation unlike denatured collagen. The CAM is colonized, 
vascularized, and persists for six months in the subcutaneous site in nude 
rats. 
3.5. Histology of processed yarn after in vivo remodeling 
Overall, the in vivo remodeling was progressive for all yarns with an 
Fig. 3. Subcutaneous implantation in nude rats. (A, 
B) Yarns were inserted under the skin of the rat using 
a 17-cm long needle and left for up to six months. (C, 
D) Yarns were easily identifiable on the underside of 
the skin six months after implantation (black arrow-
heads). (E) A strip of a bovine collagen membrane 
used clinically for oral surgery served as a positive 
control for innate immune response. (F) After one 
month, the membrane of processed collagen turned 
brown (black arrowheads) and was degraded. (For 
interpretation of the references to color in this figure 
legend, the reader is referred to the Web version of 
this article.)   
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inflammatory response at two weeks that was largely resolved at one 
month followed by a seemingly stable state at three and six months 
(Fig. 5 and Fig. S5). After two weeks, host fibroblastic cells were present 
at the surface of the decellularized yarn and some cells had migrated in 
the CAM (Fig. 5A and Fig. S4A). Mild inflammation was visible. By six 
months, the yarn looked like its devitalized counterparts, and blood 
vessels could occasionally be seen deep in the core of the yarns (Fig. 5B 
and Fig. S4B). In contrast, at two weeks, gamma sterilized yarns 
generated a more intense inflammatory reaction with abundant immune 
cells and blood vessels deep inside the yarn structure, although generally 
not penetrating the CAM itself (Fig. 5C and Fig. S4B). At six months, the 
gamma sterilized yarns were sparsely populated with fibroblastic cells 
lodged in a loose conjunctive tissue and showed reduced signs of 
inflammation (Fig. 5D and Fig. S4A). The layers of gamma sterilized 
CAM appeared generally thinner than those of other yarns but this was 
not confirmed statistically (Fig. 5D and Fig. S4C). The twisting process 
compacted the CAM which seemed to reduce cell migration in the core 
of the yarn (Fig. 5E and Fig. S4A). Indeed, accumulations of fibroblastic 
cells, immune cells, and blood vessels were limited to the periphery of 
the yarns. However, after six months, the twisted yarn appeared to have 
unwound as it was much less compact (Fig. 5F). It looked similar to 
devitalized yarn with a resolved inflammation, sparse fibroblastic cells, 
and limited vascularization (Fig. S4A, B). These results show that 
decellularization and twisting of the yarn did not affect its ability to be 
accepted by the host while gamma sterilization sufficiently modified the 
CAM to trigger an enhanced inflammatory reaction. However, all yarns 
appeared well integrated after six months. 
3.6. Distribution of three major CAM proteins during in vivo remodeling 
To further study the in vivo remodeling of the yarns, we analyzed by 
immunofluorescent staining the distribution of three key ECM proteins 
previously identified in the CAM [15] (type I collagen, thrombospondin, 
and fibronectin) (Fig. 6). Type I collagen was homogeneously distrib-
uted through the thickness of all yarns, and its distribution did not 
change over time after implantation (Fig. 6A–H, Fig. S6A-D and 
Fig. S7A-D). Thrombospondin, which was highly expressed in the CAM 
before implantation, disappeared after one month of implantation from 
all yarns except from the gamma sterilized yarns, which, while only 
faintly stained before implantation, were still stained after six months 
(Fig. 6I-P, Fig. S6E-H, and Fig. S7E-H). Fibronectin was concentrated on 
the outer surfaces of the devitalized CAM, presumably where cells were 
actively growing. The protein was slowly lost over the six months of 
implantation in all yarns (Fig. 6Q–X, Fig. S6I-L, and Fig. S7I-L). 
Conversely, gamma sterilized yarns were poorly stained for the fibro-
nectin at T = 2w, but they remained positive over six months of 
remodeling. This data demonstrates that, independently of the 
manufacturing process, type I collagen remained abundant within the 
CAMs over six months of implantation, while thrombospondin and 
fibronectin proteins were degraded over time. 
(caption on next column) 
Fig. 4. In vivo remodeling of devitalized yarn. (A–E) Histological cross-sections 
at two weeks (T = 2w), as well as one (T = 1 m), three (T = 3 m), and six 
months (T = 6 m) after subcutaneous implantation in nude rats (H&E). (A) 
After two weeks, mild inflammation was observed around the devitalized yarns 
(Devit) and rounded dark cells were seen in the CAM (red arrows). Fibroblastic 
cells (black arrows) and small blood vessels (dotted lines black arrow) were 
noted between CAM layers. (B) At one month, fibroblastic cells (black arrows) 
and vascularization (dotted lines black arrows) were observed. (C, D) By three 
months and six months, a stable and sparse cell density was achieved with no 
inflammation or signs of yarn degradation. (E) The commercial collagen 
membrane (BioMend®) was mostly degraded at two weeks, and brownish, 
actively phagocytic macrophages were seen at higher magnification (black ar-
rowheads). Scale bars; 250 μm (large panels) and 50 μm (small panels). (For 
interpretation of the references to color in this figure legend, the reader is 
referred to the Web version of this article.) 
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3.7. Inflammation response during in vivo remodeling 
In order to identify the immune cells observed with basic histology, 
we quantified M1 (CCR7/CD68 positive cells; inflammation) and M2 
(CD206/CD68 positive cells; remodeling) macrophages to analyze the 
inflammatory response to the various processed yarns (Fig. 7). First, the 
inflammatory response to fresh and devitalized yarns were compared 
(Fig. S8). Macrophage density was very low for M1 and M2, and 
decreased overtime for both yarns (Fig. S8A) showing a very mild in-
flammatory response to the material. There were no significant differ-
ences between the yarns for the density of M1 or M2 macrophages, or 
their ratios, at any time point (Fig. S8). In a second set of experiments, 
we compared processed yarns to our “control”: the devitalized yarn 
(Fig. 7). Gamma sterilized yarn showed a statistically higher density of 
macrophages expressing an inflammatory M1 phenotype than other 
yarns (Fig. 7Q: Gamma Ster T = 0 vs Devit T = 0, Decell T = 0, and 
Twisted T = 0: ##P < 0.01). However, M1 density at the implantation 
sites of gamma sterilized yarn significantly decreased over time and 
reached values as low as that of the other yarns at six months, suggesting 
a resolution of the inflammation (Fig. 7Q: T = 2w vs T = 1 m: **P < 0.01; 
T = 2w vs T = 3 m: ****P < 0.0001; T = 2w vs T = 6 m: ****P < 0.0001). 
M2 macrophages displayed a similar density and decrease over time for 
all yarns except for the gamma sterilized yarn which was more inflam-
matory (Fig. 7R: Gamma Ster T = 2w vs T = 6 m: *P < 0.05). Finally, 
M1/M2 ratios did not statistically vary with time or between the yarns 
(Fig. 7S). 
3.8. Mechanical properties of yarns before and after in vivo remodeling 
In a first experiment, we implanted fresh yarns containing living cells 
and devitalized yarns to assess if the devitalization processing would 
denature the CAM. Samples of around 10-cm long were harvested for 
each yarn to determine their force at failure and ultimate tensile stress 
(UTS) after up to six months of in vivo remodeling (Fig. S9). No signifi-
cant differences were observed between fresh and devitalized yarn 
strength (force at failure) prior or during the six-month-implantation 
period, which confirmed that the devitalization process did not dena-
ture the CAM enough to trigger an innate immune response. Analysis of 
the UTS showed a drastic increase with longer periods of implantation, 
which was the result of a decrease in yarn diameters (Fig. S9B). This is 
suggestive of tissue compaction. We observed a higher variability at 
later time points (Fig. S9A and B; T = 3 m and T = 6 m). This was 
attributed to damage caused to yarns during the harvest dissection, 
which became more challenging as implantation time increased. 
In a second experiment, we wanted to examine the effects of addi-
tional processing steps that could be relevant for the manufacturing of 
therapeutic products using biological yarns. These included: active 
decellularization to remove cellular debris, gamma sterilization, and 
Fig. 5. Impact of processing on yarn in vivo remodeling. (A–F) H&E staining of yarn cross-sections at two weeks (T = 2w; left panels) and six months (T = 6 m; right 
panels) after subcutaneous implantation in nude rats. (A) Decellularized yarns (Decell) were already covered by rat fibroblastic cells after two weeks of implantation 
and some cells were observed in (black arrows) and on (dotted lines black arrows) the CAM. (B) By six months, the yarn looked like its devitalized counterparts and 
blood vessels could occasionally be seen deep inside the yarn (small black arrows). (C) After two weeks of implantation, gamma sterilized yarn (Gamma Ster) 
displayed a more intense inflammatory response with the presence of immune cells (black arrowheads), as well as numerous blood vessels with visible red blood cells 
(small black arrows). (D) The inflammation had subsided after six months and vascularization was visible (small black arrows). (E) The twisted yarn (Twisted) 
appeared compact and less colonized by the host’s cells after two weeks of implantation. Mild inflammation was observed around the implant (black arrowheads). (F) 
Yarn were much less compact after six months and were sparsely populated with fibroblastic cells (black arrows). Scale bars; 250 μm (large panels) and 50 μm (small 
panels). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) 
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twisting the yarn (Fig. 8). In this experiment, devitalized yarn was used 
as the reference since this is our preferred form because it allows a 
simpler manufacturing strategy. We observed lower variability in this 
experiment probably because we used a less aggressive dissection to 
avoid damaging yarns. This better resolution allowed the measurement 
of a statistically significant reduction of the force at failure of devitalized 
yarn, which occurred within two weeks after implantation (Fig. 8A). 
However, the strength of the yarn did not further decrease significantly 
over the next 5.5 months. Prior to implantation (T = 0), we observed 
that the decellularization process had no effect on yarn strength but this 
was not the case for gamma sterilization and twisting, which both 
caused a significant decreased of yarn strength by approximately 25% 
(Fig. 8A: Devit T = 0 vs Gamma Ster T = 0: ###P < 0.001; Devit T =
0 vs Twisted T = 0: ####P < 0.0001). Devitalized, decellularized, and 
gamma sterilized yarns showed significant reductions of their forces at 
failure after six months (Fig. 8A: Devit T = 0 vs T = 6 m, Decell T = 0 vs 
T = 6 m, and Gamma Ster T = 0 vs T = 6 m: ****P < 0.0001). Like 
devitalized yarn, decellularized yarn showed an early significant 
Fig. 6. In vivo remodeling of human collagen type I, thrombospondin, and fibronectin in yarns. (A–H) Independently of yarn processing, collagen type I expression 
(red) appeared unchanged after six months of remodeling (T = 6 m) in nude rats. (I–P) While thrombospondin (red) was expressed within the outer layers of yarns at 
the early time point of remodeling (T = 2w), it was completely absent from yarns at T = 6 m. (Q–X) Fibronectin (red) was already totally removed from the 
devitalized yarns, after two weeks of implantation. Scale bars; 100 μm. (For interpretation of the references to color in this figure legend, the reader is referred to the 
Web version of this article.) 
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Fig. 7. Macrophages density and phenotype in vivo remodeling of the 
yarns in nude rats. (A–P) M1 macrophages were identified using double 
immunofluorescent staining against CCR7 (red) and CD68 (green) anti-
gens, while CD206 (red) and CD68 (green) antigens were used for M2 
macrophages. Scale bars; 100 μm. (Q) M1 macrophage quantification 
showed that density decreased over time for all yarns. (R) M2 macro-
phages quantification showed density levels and a decrease over time 
that was similar to M1 macrophages. (S) M1/M2 ratios did not statisti-
cally vary over time or between yarns. (Significant differences between 
the T = 2w of each condition: ##P < 0.01 and significant differences 
between the T = 2w and other time points within the condition: **P <
0.01; ****P < 0.0001). (For interpretation of the references to color in 
this figure legend, the reader is referred to the Web version of this 
article.)   
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reduction in strength (Fig. 8A: Decell T = 0 vs T = 2w, T = 1 m, T = 3 m, 
and T = 6 m: ****P < 0.0001) with non-significant changes in strength 
up to the six-month time point. While explanted decellularized yarn 
tended to be weaker than devitalized yarn, this difference was never 
statistically significant. Unlike these two yarns, the strength of gamma 
sterilized yarn seemed to progressively decrease and became signifi-
cantly weaker than that of devitalized yarn at six months (Fig. 8A: Devit 
T = 6 m vs Gamma Ster T = 6 m: ++++ P < 0.0001), which is coherent 
with the increased inflammatory response observed by histology. Unlike 
all the other yarns, the much denser twisted yarn did not lose significant 
mechanical strength at any point after implantation, suggesting that the 
high compaction of the matrix made it more resistant to early in vivo 
remodeling. Overall, after six months of in vivo remodeling, devitalized, 
decellularized, and twisted yarns showed the same stable force at fail-
ure, which was approximately 50% of the initial force of the devitalized 
yarn at T = 0. 
The UTS of the devitalized CAM was 3.4 ± 1.2 MPa and remained 
constant after implantation. Decellularization of the yarn significantly 
increased the UTS at T = 0 (Fig. 8B: Devit T = 0 vs Decell T = 0: ####P 
< 0.0001) because it compacted the matrix and resulted in a smaller 
diameter. However, the UTS of decellularized yarn decreased to devi-
talized levels within two weeks after implantation (Fig. 8B: Decell T =
0 vs T = 2w: ****P < 0.0001) largely due to an apparent increase in 
diameter. UTS then changed with time following the pattern observed 
for the force at failure (Fig. 8A) because the diameter was stable. Gamma 
sterilization caused a decrease in yarn diameter resulting in a UTS that 
was equal to that of non-sterilized devitalized yarn (Fig. 8B). The UTS 
did not significantly change during the implantation period although it 
trended down with time like the force at failure. Twisting at 7.5 rev/cm, 
which is a high level of compaction, tripled the UTS of the yarn (Fig. 8B: 
Devit T = 0 vs Twisted T = 0: ####P < 0.0001). The UTS significantly 
dropped in the first two weeks of implantation (Fig. 8B: Twisted T = 0 vs 
T = 2w: ****P < 0.0001) but remained stable for the remainder of the 
experiment. These results were driven by an increase in diameter due to 
the unwinding of the yarn, based on histology results. Taken together, 
this data shows how different processing can affect yarn mechanical 
properties and their evolution after in vivo implantation. 
4. Discussion 
Medical textiles have been used in vascular surgery for decades: from 
simple sutures to complex covered stents [16]. We have previously 
demonstrated that we can produce completely biological human textiles 
using yarn of cell-assembled extracellular matrix (CAM) produced in the 
laboratory [8]. In the context of small-caliber vessels replacement, we 
have shown that a TEVG produced from woven CAM yarn has me-
chanical properties that exceed the requirement for in vivo implantation. 
We have previously shown that TEVGs obtained by rolling human CAM 
Fig. 8. Evolution of the yarn mechanical properties 
after in vivo remodeling in nude rats for up to six 
months. (A) Tensile force at failure of yarns as a 
function of processing and implantation time. (B) 
Ultimate Tensile Stress (UTS) of yarns as a function of 
processing and implantation time. UTS evolution was 
largely guided by force at failure since the diameter 
did not change at longer time points. (Significant 
differences between the T = 0 of each condition: ##P 
< 0.01; ###P < 0.001; ####P < 0.0001, significant 
differences between the T = 6 m of each condition: +
P < 0.05; ++++ P < 0.0001, and significant differ-
ences between the T = 0 and other time points within 
the condition: **P < 0.01; ***P < 0.001; ****P <
0.0001).   
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sheets demonstrated promising outcomes as an arteriovenous shunt in 
patients for over 20 months (up to 36 months, unpublished data) [1,5]. 
While these clinical results established the long-term in vivo persistence 
of the CAM, they yielded little information on its remodeling process. In 
this study, we aimed to analyze the CAM remodeling in a much more 
controlled environment and using a simpler implant to gather both 
histological and mechanical information. We also wanted to assess how 
CAM processing could affect its in vivo remodeling. Results showed that 
the CAM yarn caused a very mild inflammatory response that quickly 
subsided to allow the material to fully integrate and persist in a nude rat 
model for at least six months. 
In this study, immunodeficient rat model was selected to evaluate the 
innate immune response (inflammation) while avoiding any rejection of 
xenogeneic material (human CAM) by the adaptive immune system [9, 
17]. To prove that the nude rat innate immune system was functional, 
we implanted a clinically available reconstituted collagen membrane 
and, as expected, this denatured collagen was aggressively degraded. 
The membrane, which has a predicted life of eight weeks in humans, 
according to the manufacturer, was already irretrievable two weeks 
after implantation. In contrast, our human “bio” material (CAM) was 
easily identified and could be explanted after six months. The subcu-
taneous space is a standard site for biocompatibility studies (ISO 
10993–6:2016) and made possible the implantation and retrieval of long 
yarn segments. This allowed direct mechanical testing on many, rela-
tively large, samples to provide more direct, and potentially more reli-
able, data than is possible with miniaturized of indirect measurements 
strategies that are needed for smaller implants. Nevertheless, the 
remodeling observed here may not be directly transposable to other 
implantation sites. In addition, this model does not allow the study of 
allogeneic immune responses. However, results from our group and 
others suggest that allogenic responses to tissue-engineered constructs 
are not significant enough to jeopardize tissue function [2,6,18]. In 
order to study allogeneic responses, we are developing a large animal 
model where ovine CAM yarns and TEVGs will be grafted in sheep to 
assess long-term in vivo remodeling (one year). 
Mechanically, fresh and devitalized yarns were not significantly 
different before or after implantation (Fig. S9). This is in agreement with 
our previous results showing that CAM organization is not substantially 
affected by the devitalization process [15]. The in vivo remodeling of 
fresh yarns was slightly different as more cells were present at all times 
(Fig. S1), suggesting that human fibroblastic cells within the CAM can 
survive implantations. In addition, more blood vessels were observed in 
the fresh CAM yarns, which may be the consequence of having living 
mesenchymal cells that secrete paracrine signals (vascular endothelial 
growth factors or angiopoietins) promoting revascularization after im-
plantation [19,20]. While the in vivo remodeling of fresh CAM is inter-
esting, we focused this study on devitalized yarns because they are more 
compatible with a commercially viable strategy for human textile 
manufacturing [8]. A key objective of this study was to compare devi-
talized yarn with yarns that were further processed by either decellu-
larizing the matrix with chemicals, gamma sterilizing, or tightly twisting 
the ribbon into a compact yarn. These are all relevant processing steps 
for tissue engineering approaches, since they may reduce the inflam-
matory response, allow non-sterile yarn production and assembly, or 
tune the mechanical properties of the yarn, respectively. 
Extracellular matrix decellularization has been investigated by 
several research groups to create “off-the-shelf” tissues or organs for 
regenerative medicine applications [2,21–26]. Our data demonstrated 
that decellularized yarns had similar initial mechanical strength and in 
vivo remodeling compared to devitalized ones. While debris from dead 
cells are often cited as important inflammatory mediators [27,28], this 
was not observed in our “bio” material based on the histology results and 
sustained mechanical strength of the yarns. This is consistent with the 
successful clinical implantation of three allogeneic devitalized 
CAM-based vascular grafts [6]. This may be because cells died quickly 
without going into apoptosis or other types of programmed cell death. In 
addition, the decellularization process did not seem to denature the 
matrix significantly. While the data suggest that this process does not 
modify the CAM properties, it appears to be an unnecessary additional 
step that may create the risk of leaving chemical residues [29]. 
One of the main challenges in the manufacturing of a biological 
product is to ensure sterility during its manufacturing. While we have 
shown that CAM can be produced sterilely under good manufacturing 
practices (GMP) conditions [1,5,6], terminal sterilization can be a 
convenient and economical manufacturing step. Gamma irradiation is a 
widely used sterilization process to guarantee the safety of 
collagen-based materials [30–32]. In this study, we showed that this 
treatment affected the CAM by decreasing its mechanical strength, 
changing its histological appearance, modifying its affinity for stains, 
and even affecting the remodeling of an important matrix protein 
(Thrombospondin) (Fig. S6). At the time of implantation, the gamma 
sterilized yarn even felt different as it was more transparent, stiffer, and 
more hydrophobic. Consistent with our results, Dearth et al. demon-
strated that the gamma sterilization process significantly reduced the 
mechanical properties (burst strength and suture retention) of porcine 
dermal ECM scaffold materials, and the impact was dose-dependent 
[33]. In addition, they also showed that the increase of gamma irradi-
ation dosages elicits an augmented rate of biomaterial degradation 
following 35 days of implantation in the abdominal walls of rats [33]. It 
was also demonstrated that it could severely damage collagen fibers, via 
crosslinking and/or peptide chain scission [34–38]. Similarly, we found 
that gamma sterilization also influenced the remodeling process as it 
significantly increased the density of M1 macrophages at early time 
points (two weeks) in nude rats. Nonetheless, this inflammatory 
response was resolved after six months, which leaves the possibility of 
using this process if these changes are taken into account in the product 
design. Future studies will explore other sterilization methods, such as 
ethylene oxide, e-beam, supercritical CO2, or liquid chemicals, in order 
to identify the least denaturing process for our collagen-based “bio” 
material. 
We also analyzed the in vivo remodeling of compacted twisted yarns 
after implantation. Indeed, this process can be crucial in the production 
of human textiles in order to tune their mechanical behavior [8]. 
Interestingly, twisting the CAM yarns decreased the force at failure but 
significantly increased the UTS of the “bio” material. It also protected it 
from the initial inflammatory response of the host, which caused a sig-
nificant early decrease in mechanical strength of all other yarns within 
the first two weeks. Histological analyses suggested that this was due to 
tissue compaction that prevented access by inflammatory cells to the 
core of the CAM at the early time point (two weeks). With time, twisted 
yarns were less compact on histology, as they probably unwound 
because of residual tensions in the CAM, but by then, the mild and 
transient inflammatory response was over. 
Quantification of M1/M2 macrophages failed to show significant 
differences. This was linked to the large variability which was the result 
of the low macrophage counts combined with the usual animal-to- 
animal variability. Similar difficulty in achieving significance was also 
reported by Korzinskas et al. with similarly low macrophage densities 
[39]. 
Using a textile-based manufacturing approach, we have demon-
strated our ability to use CAM yarns for the production of small diameter 
woven TEVGs with supraphysiological strength [8]. Such TEVGs could 
tolerate a significant loss of mechanical strength during their in vivo 
remodeling so the weakening of the CAM after the transient acute 
inflammation caused by the implantation should not be problematic for 
their success a vascular conduit. In that same study, we also showed that 
CAM yarns could be used a suture material to close a wound in a nude 
rat. Full wound closure and healing was achieved with no macroscopic 
signs of inflammation. Histological staining after one month confirmed 
the persistence of the CAM in the skin while it disappeared from the 
surface of the wound after two weeks. This result is consistent with the in 
vivo behavior observed in the current study and confirms the potential of 
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CAM-based material for clinical applications. 
5. Conclusion 
This study was the first formal evaluation of CAM remodeling in vivo. 
At the end of the six-month implantation period, yarns were well inte-
grated in a loose conjunctive tissue with no signs of chronic inflamma-
tion (no inflammatory foci, no giant cells, no phagocytizing 
macrophages or calcification). No dense or acellular fibrous encapsu-
lation was observed. After three months, all yarns were characterized by 
a sparse population of fibroblastic cells within the CAM and occasional 
blood vessels. The same observations were made at six months, sug-
gesting a stable remodeling. Taken together, these results demonstrate 
that the CAM is a long-lived biological material that causes little 
inflammation and fully integrates in the host after implantation. 
Consequently, CAM yarns are promising materials to produce 
completely biological human textiles for various regenerative medicine 
applications where low inflammatory responses, sustained mechanical 
strength, or a slow remodeling process are essential. 
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